Navigation Links
Dohmen to Sell Restat, its Pharmacy Benefit Manager (PBM) Division to Catamaran
Date:8/1/2013

Milwaukee, WI (PRWEB) August 01, 2013

Catamaran, the industry’s fastest-growing pharmacy benefit manager, will buy Milwaukee, WI-based Restat, from its parent company Dohmen, for $409.5 million in a transaction expected to close in the fourth quarter of 2013, the companies announced today.

Catamaran CEO Mark Thierer said the addition of Restat will create immediate value for clients and members of both organizations. “As one of the largest privately held pharmacy benefit managers, Restat’s core business is perfectly aligned with Catamaran’s. We have a full suite of services that will complement the strengths of Restat to create a unique go-to-market PBM.”

Dohmen CEO Cynthia (Dohmen) LaConte agrees, “Dohmen’s been committed to creating efficiencies in healthcare supply for over 155 years, so it was important for us to partner with a company that could lower prescription drug costs without compromising care. Catamaran has a unique track record of achieving the right balance of scale and service. Joining Catamaran will create an even stronger marketplace offering in cost, clinical capability and customer service.”

LaConte said the sale of Restat is part of Dohmen’s strategic plan to grow and strengthen its life science service offering. “We’ve decided to exit the pharmacy benefit management business so we can focus exclusively on our life science clients. Dohmen has a long history of anticipating transformative change and building better business models to meet it, and our industry is facing a significant paradigm shift from volume to value. We think we’re uniquely positioned to help drug, device and personalized medicine companies make this transition.”

The agreement to sell Restat, was signed by Catamaran and Dohmen on July 31, 2013, and is set to close in the fourth quarter of 2013.

About Dohmen
Founded in 1858, Dohmen is a life science services company dedicated to creating a safer, more effective healthcare supply system. As the trusted partner to more than 600 BioPharma and Medtech innovators, Dohmen propels start-up, mid-tier and Fortune 500 companies with support services that span the commercialization continuum from pre-approval regulatory consulting to in-home patient services. Privately held and conflict free, Dohmen is uniquely positioned to propel personalized healthcare for life science innovators and individuals.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10986794.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dohmen’s BioSoteria Calls for Abstracts for its Seventh Annual Pacific Drug Safety Summit (PDSS)
2. Pharmacy Robots Linked to Bacterial Contamination of Drugs
3. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
4. Second Compounding Pharmacy Shut Down in Massachusetts
5. Company With Links to Meningitis-Linked Pharmacy Recalls All Products
6. Company With Ties to Meningitis-Linked Pharmacy Recalls All Products
7. Owner of Meningitis-Linked Pharmacy Declines to Testify Before Congress
8. Women’s Excellence in Bladder Control Partners with University Compounding Pharmacy in Troy, MI to Help Women with Chronic Pelvic Pain Conditions
9. Pharmacy researcher finds most popular weight-loss drug strongly alters other drug therapies
10. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
11. FDA, States Weigh Pharmacy Regulation in Wake of Meningitis Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... with an Award of Distinction, recognizing the organization as a top behavioral service ... in the areas of clinical quality, staff satisfaction and qualifications, and consumer satisfaction. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... fields in research and development, largely due to its potential for revolutionizing human ... cells (hMSCs) and human induced pluripotent stem cells (hiPSCs). , Both platforms ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... a one-stop portal for all the knowledge resources, including white papers, guides, handbooks, ... and more. , To access more than 9,000 documents, webinars and videos ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty Technical ... updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain ... the scope of their EHS regulatory obligations and rapidly collect, share, archive, and ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... announced the presentation of preclinical and manufacturing data that support ... 58 th Annual Meeting of the American Society of ... , from December 3-6, 2016. "We have ... A which we believe is highly competitive, and we remain ...
(Date:12/5/2016)... Dec. 5, 2016  Parallax Health Sciences, Inc. ("Parallax" ... announce that its pharmaceutical business, RoxSan Pharmacy, Inc. has ... coverage in all of the 42 states it is ... Michael Rashti Pharm . D, Pharmacist in Charge ... for our business. Medicare B spending last year came ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. ... the Commercialization of Public Research (the Florida ... funding agreement SegAna, LLC, an Orlando ... of Central Florida. The Florida Institute supports new ... early funding gaps for companies spinning out of Florida-based ...
Breaking Medicine Technology: